Proteomic analysis of Down's syndrome patients with gout

Clinica Chimica Acta

Volumn 369, Issue 1, 2006, Pages 89-94

  Chen, Ying Chou ^a,b   Wang, Pei Wen ^b   Pan, Tai Long ^b   Wallace, Christopher Glenn ^a   Chen, Chung Jen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Down syndrome; Gout; HPRT; Proteomic tools

Indexed keywords

APOLIPOPROTEIN A1; HAPTOGLOBIN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; URIC ACID;

ADULT; ALPHA CHAIN; AMINO ACID SEQUENCE; ARTICLE; BLOOD SAMPLING; CASE REPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; DOWN SYNDROME; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; GOUT; HUMAN; IMMUNOBLOTTING; LIPID METABOLISM; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL ELECTROPHORESIS; URIC ACID URINE LEVEL;

ADULT; BLOOD PROTEINS; DOWN SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GOUT; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PROTEOMICS; RNA, MESSENGER;

EID: 33646868385     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.01.018     Document Type: Article

References (27)

1. Zitnanova I., Korytar P., Aruoma O.I., et al. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?. Clin Chim Acta 341 1-2 (2004) 139-146
2. Pelsman A., Hoyo-Vadillo C., Gudasheva T.A., Seredenin S.B., Ostrovskaya R.U., and Busciglio J. GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. Int J Dev Neurosci 21 3 (2003) 117-124
3. Chen Y.C., and Chang H.W. Clincial manifestations of young gout patients in Taiwan. J Rheumatol, R.O.C. 16 1-2 (2002) 29-37
4. Lin K.C., Lin H.Y., and Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 27 6 (2000) 1501-1505
5. Lin K.C., Lin H.Y., and Chou P. Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. J Rheumatol 27 4 (2000) 1045-1050
6. Wilson J.M., Young A.B., and Kelley W.N. Hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular basis of the clinical syndromes. N Engl J Med 309 15 (1983) 900-910
7. Kaufman J.M., and O'Brien W.M. Hyperuricemia in mongolism. N Engl J Med 276 17 (1967) 953-956
8. Pant S.S., Moser H.W., and Krane S.M. Hyperuricemia in Down's syndrome. J Clin Endocrinol Metab 28 4 (1968) 472-478
9. Kamatani N., Yamanaka H., Tokokawa S., Kashiwazaki S., and Higurashi M. Down syndrome with coexistence gout: report of six patients and possible reasons for the scarcity of descriptions of this association. Ann Rheum Dis 55 9 (1996) 649-650
10. Ciompi M.L., Bazzichi L.M., Bertolucci D., et al. Uric acid metabolism in two patients with coexistent Down's syndrome and gout. Clin Rheumatol 3 2 (1984) 229-233
11. Binz P.A., Muller M., Hoogland C., et al. The molecular scanner: concept and developments. Curr Opin Biotechnol 15 1 (2004 (Feb)) 17-23
12. Sanches J.C., Corthals G.L., and Hochstrasser D.F. Biomedical applications of proteomics (2004), Wiley-VCH
13. Righetti P.G., Castagna A., Antonucci F., et al. Proteome analysis in the clinical chemistry laboratory: myth or reality?. Clin Chim Acta 357 (2005) 123-139
14. Jacomelli G., Micheli V., Peruzzi L., et al. Simple non-radiochemical HPLC-linked method for screening for purine metabolism disorders using dried blood spot. Clin Chim Acta 324 1-2 (2002) 135-139
15. Hikita M., Hosoya T., Ichida K., et al. Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase manifesting as acute renal damage. Intern Med 37 11 (1998) 945-949
16. Wang P.W., Chang W.N., Lu C.H., Chao D., Schrag C., Pan T.L., et al. New insights into the pathological mechanisms of cerebrotendinous xanthomatosis in the Taiwanese using genomic and proteomic tool. Proteomics 6 (2006) 1029-1037
17. Pusch W., and Kostrzewa M. Application of MALDI-TOF mass spectrometry in screening and diagnostic research. Curr Pharm Des 11 (2005) 2577-2591
18. Yu K.H., Rustgi A.K., and Blair I.A. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 4 (2005) 1742-1751
19. Gregoric A., Rabelink G.M., Vokac N.K., Varda N.M., and Zagradisnik B. Eighteen-year follow-up of a partial hypoxanthine phosphoribosyltransferase deficiency and a new mutation. Pediatr Nephrol 20 9 (2005) 1346-1348
20. Tarak S.J., Patrick O., Majed D., and Ari M.S. Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. Am J Med Genet 108 (2002) 219-222
21. de Haan J.B., Susil B., Pritchard M., and Kola I. An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the "gene dosage effect" hypothesis. J Neural Transm Suppl 67 (2003) 67-83
22. Lim S.K. Consequences of haemolysis without haptoglobin. Redox Rep 6 6 (2001) 375-378
23. Balestrieri M., Cigliano L., Simone M.L., Dale B., and Abrescia P. Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid. Mol Reprod Dev 59 2 (2001) 186-191
24. Lacko A.G., Hayes J.D., McConathy W.J., Lacko I., and Redheendran R. Lecithin: cholesterol acyltransferase in Down's syndrome. Clin Chim Acta 132 (1983) 133-141
25. Ciompi M.L., Bazzichi L.M., Bertolucci D., et al. Uric acid metabolism in two patients with coexistent Down's syndrome and gout. Clin Rheumatol 3 (1984 (Jun)) 229-233
26. Yagame M. Specificity of IgA antibodies in sera from patients with IgA nephropathy. Nippon Jinzo Gakkai Shi 34 (1992) 353-360
27. Mikkelsen W. The epidemiology of hyperuricaemia and gout. In: Smyth C., and Holers V. (Eds). Gout, hyperuricaemia, and other crystal-associated arthropathies (1999), Marcel Dekker, New York 107-119